A prospective evaluation of plasma polyphenol levels and colon cancer risk. Issue 7 (11th June 2018)

• Record Type: Journal Article
• Authors: Murphy, Neil; Achaintre, David; Zamora‐Ros, Raul; Jenab, Mazda; Boutron‐Ruault, Marie‐Christine; Carbonnel, Franck; Savoye, Isabelle; Kaaks, Rudolf; Kühn, Tilman; Boeing, Heiner; Aleksandrova, Krasimira; Tjønneland, Anne; Kyrø, Cecilie; Overvad, Kim; Quirós, J. Ramón; Sánchez, Maria‐Jose; Altzibar, Jone M.; María Huerta, José; Barricarte, Aurelio; Khaw, Kay‐Tee; Bradbury, Kathryn E.; Perez‐Cornago, Aurora; Trichopoulou, Antonia; Karakatsani, Anna; Peppa, Eleni; Palli, Domenico; Grioni, Sara; Tumino, Rosario; Sacerdote, Carlotta; Panico, Salvatore; Bueno‐de‐Mesquita, H. B(as); Peeters, Petra H.; Rutegård, Martin; Johansson, Ingegerd; Freisling, Heinz; Noh, Hwayoung; Cross, Amanda J.; Vineis, Paolo; Tsilidis, Kostas; Gunter, Marc J.; Scalbert, Augustin;
• Is Part Of: International journal of cancer. Volume 143:Issue 7(2018)
• Page Start: 1620
• Page End: 1631
• Publication Date: 2018-06-11
• Subjects: colon cancer -- polyphenols -- biomarkers -- EPIC -- nested case–control study; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.31563
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract : Polyphenols have been shown to exert biological activity in experimental models of colon cancer; however, human data linking specific polyphenols to colon cancer is limited. We assessed the relationship between pre‐diagnostic plasma polyphenols and colon cancer risk in a case–control study nested within the European Prospective Investigation into Cancer and Nutrition study. Using high pressure liquid chromatography coupled to tandem mass spectrometry, we measured concentrations of 35 polyphenols in plasma from 809 incident colon cancer cases and 809 matched controls. We used multivariable adjusted conditional logistic regression models that included established colon cancer risk factors. The false discovery rate ( q values ) was computed to control for multiple comparisons. All statistical tests were two‐sided. After false discovery rate correction and in continuous log2 ‐transformed multivariable models, equol (odds ratio [OR] per log2 ‐value, 0.86, 95% confidence interval [95% CI] = 0.79–0.93; q value = 0.01) and homovanillic acid (OR per log2 ‐value, 1.46, 95% CI = 1.16–1.84; q value = 0.02) were associated with colon cancer risk. Comparing extreme fifths, equol concentrations were inversely associated with colon cancer risk (OR = 0.61, 95% CI = 0.41–0.91, p trend = 0.003), while homovanillic acid concentrations were positively associated with colon cancer development (OR = 1.72, 95% CI = 1.17–2.53, p trend < 0.0001). No heterogeneity for these associations was observed by sex and across other colon cancer risk factors. The remaining polyphenols were not associated with colon cancer risk. Higher equol concentrations were associated with lower risk, and higher homovanillic acid concentrations were associated with greater risk of colon cancer. These findings support a potential role for specific polyphenols in colon tumorigenesis. Abstract : What's new? Polyphenols are antioxidants abundant in food, and some polyphenols have demonstrated an anti‐cancer effect. Here, the authors looked for an association between polyphenols and colon cancer risk by conducting a nested case–control analysis within the EPIC cohort. Rather than employing questionnaires that rely on participant memories of their diet, this study directly measured 35 polyphenols in plasma samples and compared them with colon cancer risk. Only 2 chemicals showed any association. Concentrations of equol, which is metabolized from soy foods, were inversely associated with colon cancer risk. Higher levels of homovanillic acid, on the other hand, were associated with increased risk.